Immatics N.V. Ordinary Shares – Chart, Kurs & Nachrichten (NASDAQ:IMTX) | MetaTrader

Vollständige Grafik anzeigen Full chart

Financials

Übersicht Finanzbericht Statistik

Vierteljährlich Jährlich

Market Capitalization 15.43 M
Employee 407
Founded 2000
CEO Harpreet Singh
Website www.immatics.com
Headquarter Netherlands
FIGI N/A
Industry Biotechnologie

Nachrichten

Immatics NV: EPS verfehlt Schätzungen um 0,04 € - Umsatz schlechter als erwartet

Immatics (IMTX) Reports Q1 Loss, Lags Revenue Estimates

ACAD Q1 Earnings & Revenues Miss Estimates Despite Y/Y Sales Growth

Madrigal Q1 Earnings Beat, MASH Drug Sales Drive Top Line, Stock Up

RXRX Q1 Loss Narrower Than Expected, Revenues Decline Y/Y

Prime Medicine, Inc. (PRME) Reports Q1 Loss, Misses Revenue Estimates

All You Need to Know About Immatics (IMTX) Rating Upgrade to Buy

NVO Q1 Earnings & Sales Top Estimates, 2026 Outlook Raised, Stock Up

Twist Bioscience (TWST) Reports Q2 Loss, Beats Revenue Estimates

Immatics: TD Cowen startet Coverage mit Kaufempfehlung

Immatics präsentiert auf ASCO-Jahrestagung vier Studien zu Krebstherapien

Immatics: Buying The Anzu-Cel Floor, Playing The Moderna Moonshot (NASDAQ:IMTX)